<think>Let me carefully analyze this medical records document to extract all valid medical visits according to the specified criteria.

First, I need to identify all potential encounters, then filter based on the rules:

1. **Extraction:** Identify all potential encounters.
2. **Inclusion Filtering:** A visit is valid if it has at least a Facility Name OR a Provider Name explicitly present in the text.
3. **Scope Filtering:** 
   - Discard all legal events (depositions, legal reviews).
   - Discard "Provider Lists", "Directories", "Staff Updates", "Medical Provider List Updates", or "Summaries of Treating Providers".
   - Discard non-medical events (billing, admin).
4. **Sorting:** Sort valid visits chronologically.
5. **Deduplication:** Ensure distinct appointments on the same day are listed as separate entries.

Let me go through the document:

**Page 1 (DOC ID: SUMMIT-NEURO-20250310-001):**
- DATE OF SERVICE: March 10, 2025
- PROVIDER: Dr. Wendy Nakamura, MD
- FACILITY: Summit Neurology Associates
- This is a clinical visit - VALID

**Page 2 (DOC ID: SUMMIT-NEURO-20250310-002):**
- DATE OF STUDY: March 10, 2025
- FACILITY: Summit Imaging Center
- RADIOLOGIST: Dr. Elias Vance, MD
- This is a clinical imaging visit - VALID

**Page 3 (DOC ID: Clearwater-Neuro-20250422-001):**
- DATE OF SERVICE: April 22, 2025
- EVALUATING PSYCHOLOGIST: Dr. Thomas Reeves, PhD, ABPP-CN
- FACILITY: Clearwater Neuropsychology Center
- This is a clinical visit - VALID

**Page 4 (DOC ID: ClearPath-PA-20250401-001):**


- This is a prior authorization request form - NOT a clinical visit, discard.

**Page 5 (DOC ID: SUMMIT-NEURO-20250605-001):**
- DATE: June 5, 2025
- PROVIDER: Dr. Wendy Nakamura, MD
- FACILITY: Summit Neurology Associates
- This is a clinical visit - VALID

**Page 6 (DOC ID: PT-Referral-20250515):**
- This is a referral confirmation - NOT a clinical visit, discard.

**Page 7 (DOC ID: PINEPT-20250728-001):**
- DATE OF EVALUATION: July 28, 2025
- THERAPIST: Sarah Mitchell, DPT
- FACILITY: Pinecrest Physical Therapy & Rehabilitation
- This is a clinical visit - VALID

**Page 8 (DOC ID: PINEPT-20250728-002):**
- DATE: July 28, 2025
- This appears to be additional documentation from the same visit on Page 7 - likely part of the initial evaluation.

**Page 9 (DOC ID: Scheduling-Confirm-20250810):**
- This is an appointment confirmation - NOT a clinical visit, discard.

**Page 10 (DOC ID: SUMMIT-NEURO-20250915-001):**
- DATE OF VISIT: September 15, 2025
- PROVIDER: Dr. Wendy Nakamura, MD
- FACILITY: Summit Neurology Associates
- This is a clinical visit - VALID

**Page 11 (DOC ID: RIDGEVIEW-OM-20251020-001):**
- DATE OF EVALUATION: October 20, 2025
- PHYSICIAN: Dr. Frank Delgado, MD, MPH
- FACILITY: Ridgeview Occupational Medicine
- This is a clinical visit - VALID

**Page 12 (DOC ID: PATHFIND-INS-20251101-001):**
- This is an insurance denial letter - NOT a clinical visit, discard.

**Page 13 (DOC ID: SUMMIT-NEURO-20251210-001):**
- DATE OF SERVICE: December 10, 2025
- PROVIDER: Dr. Wendy Nakamura, MD
- FACILITY: Summit Neurology Associates
- This is a clinical visit - VALID

**Page 14 (DOC ID: SUMMIT-NEURO-20251210-002):**
- DATE: December 10, 2025
- This is a prescription order - part of the same visit on Page 13.

**Page 15 (DOC ID: RIDGEVIEW-OM-20260218-001):**
- DATE OF EVALUATION: February 18, 2026
- PHYSICIAN: Dr. Frank Delgado, MD, MPH
- FACILITY: Ridgeview Occupational Medicine
- This is a clinical visit - VALID

**Page 16 (DOC ID: RECORDS-REQ-20260105):**
- This is a medical records request from Legal Counsel - NOT a clinical visit, discard.

**Page 17 (DOC ID: PROVIDER-UPDATE-20250615):**
- This is a provider directory update - NOT a clinical visit, discard.

**Page 18 (DOC ID: SUMMIT-BILLING-20250325):**
- This is a billing statement - NOT a clinical visit, discard.

**Page 19-20 (DOC ID: LAB-REPORT-20250310-001):**
- COLLECTION DATE: 2025-03-10
- FACILITY: Summit Clinical Laboratories
- ORDERING PROVIDER: Dr. Wendy Nakamura
- This is a laboratory report - VALID (clinical test results)

I'll organize these visits chronologically to track the patient's medical journey.

**Chronological Visit Sequence:**

1. March 10, 2025 - Summit Neurology Associates (Neurology visit)
2. March 10, 2025 - Summit Imaging Center (MRI)
3. March 10, 2025 - Summit Clinical Laboratories (Labs)
4. April 22, 2025 - Clearwater Neuropsychology Center (Neuropsychology eval)
5. June 5, 2025 - Summit Neurology Associates (Follow-up)
6. July 28, 2025 - Pinecrest Physical Therapy (Initial eval)
7. September 15, 2025 - Summit Neurology Associates (Follow-up)
8. October 20, 2025 - Ridgeview Occupational Medicine (Return-to-work eval)
9. December 10, 2025 - Summit Neurology Associates (Follow-up)
10. February 18, 2026 - Ridgeview Occupational Medicine (Final work capacity eval)

I notice multiple visits on March 10, 2025, involving different facilities. I'll need to carefully distinguish between these distinct clinical encounters.

The first visit involves Summit Neurology Associates with Dr. Wendy Nakamura, focusing on neurological evaluation. The second visit is at Summit Imaging Center, where Dr. Elias Vance conducts an MRI. The third visit occurs at Summit Clinical Laboratories, with Dr. Wendy Nakamura ordering laboratory tests.

Each visit requires separate documentation, highlighting the complexity of the patient's medical assessment on that single date.
</think>

## Date of Medical Visit: 03/10/2025
### 03/10/2025
* **Type of Visit:** Neurology Consultation
* **Facility Name:** Summit Neurology Associates
* **Provider Name:** Dr. Wendy Nakamura, MD
* **Subjective/HPI/CC/Hospital Course:** Evaluation of persistent head pain and difficulty with concentration. Patient presents following referral for assessment of recurring headaches and memory-related issues. She describes experiencing daily head discomfort for approximately six months. Pain characterized as pressure sensation affecting both sides of forehead, intensity ranging from five to seven out of ten. Associated symptoms include sensitivity to light and occasional feelings of nausea. Additionally, patient reports decline in cognitive abilities, specifically struggling with focus, finding correct words, and remembering recent information. These cognitive complaints began after a motor vehicle accident that occurred eight months prior to this visit.
* **Objective/PE:** Mental status examination revealed patient was alert and oriented to person, place, and time. All cranial nerves, from second through twelfth, were assessed and found to be intact. Motor strength was symmetrical and full (5/5) across all four extremities. Sensory perception was also intact. Cerebellar functions, including coordination and balance, appeared normal. Romberg's test yielded negative result. Mini-Mental Status Exam administered, patient scoring 28 out of 30 points. Points deducted for errors in delayed recall and serial sevens subtraction tasks.
* **Diagnoses:** Post-traumatic headache syndrome; Post-concussion syndrome with observed cognitive difficulties; Migraine without aura.
* **Medication(s):** Topiramate: Initiated at 25 milligrams once daily, with instructions to increase dosage to 50 milligrams twice a day as tolerated; Sumatriptan: Prescribed 50 milligrams to be taken as needed for acute migraine episodes.
* **Plan/Assessment:** Comprehensive neuropsychological evaluation strongly advised to objectively quantify extent of cognitive impairments. Patient instructed to maintain detailed headache diary for next four weeks. If frequency or severity of headaches does not show improvement, Magnetic Resonance Angiography (MRA) scan will be considered. Follow-up appointment scheduled for six weeks from today's date. Referral placed for neuropsychological testing.
* **Source References:** (DOC ID: SUMMIT-NEURO-20250310-001 | PAGE 1 of 42)

### 03/10/2025
* **Type of Visit:** MRI Brain w/ and w/o Contrast
* **Facility Name:** Summit Imaging Center
* **Provider Name:** Dr. Elias Vance, MD
* **Imaging:** MRI BRAIN W/ AND W/O CONTRAST: No evidence of acute infarct, hemorrhage, or mass lesion. Ventricular system, sulci, and gyri appear normal for age. No hydrocephalus or significant atrophy. Scattered small, nonspecific areas of T2/FLAIR hyperintensity observed within bilateral frontal lobes. These are non-enhancing and could be consistent with sequelae of prior trauma or chronic microvascular changes. No evidence of significant stenosis, aneurysm, or arteriovenous malformation on standard sequences. Orbits/sinuses/mastoids unremarkable. Cerebellum and brainstem appear normal. No abnormal intracranial enhancement identified.
* **Diagnoses:** No acute intracranial pathology; Small, nonspecific white matter hyperintensities in bilateral frontal lobes, etiology non-specific but could represent post-traumatic changes given clinical history; No evidence of mass effect or midline shift.
* **Source References:** (DOC ID: SUMMIT-NEURO-20250310-002 | PAGE 2 of 42)

### 03/10/2025
* **Type of Visit:** Laboratory Work
* **Facility Name:** Summit Clinical Laboratories
* **Provider Name:** Dr. Wendy Nakamura, MD
* **Labs:** All values within normal limits: CBC (WBC 7.2, RBC 4.50, Hemoglobin 13.8, Hematocrit 41.5, MCV 92, MCH 30.7, MCHC 33.2, Platelets 280, RDW 13.0); CMP (Glucose 95, BUN 15, Creatinine 0.85, eGFR >60, Sodium 140, Potassium 4.1, Chloride 102, CO2 25, Calcium 9.2, Total Protein 7.0, Albumin 4.2, Total Bilirubin 0.5, Alkaline Phosphatase 70, AST 22, ALT 18); TSH 2.15.
* **Source References:** (DOC ID: LAB-REPORT-20250310-001 | PAGE 19 of 42)

## Date of Medical Visit: 04/22/2025
### 04/22/2025
* **Type of Visit:** Comprehensive Neuropsychological Evaluation
* **Facility Name:** Clearwater Neuropsychology Center
* **Provider Name:** Dr. Thomas Reeves, PhD, ABPP-CN
* **Subjective/HPI/CC/Hospital Course:** Patient underwent comprehensive neuropsychological assessment to investigate ongoing cognitive complaints, specifically related to attention, memory, and executive functions, which she attributes to motor vehicle collision occurring eight months ago. She asserts she did not experience any cognitive problems prior to the accident. Currently not employed. Resides independently and reports no difficulties managing basic activities of daily living.
* **Objective/PE:** Tests administered: WAIS-IV, WMS-IV, Trail Making Test Parts A and B, Stroop Color-Word Test, Wisconsin Card Sorting Test, Boston Naming Test, CVLT-II, Rey Complex Figure Test, Conners CPT-3, MMPI-2-RF, TOMM. Processing Speed: Low average range, SS 85. Attention and Concentration: Borderline, SS 78. Verbal Memory: Low average range, SS 82. Visual Memory: Average range, SS 95. Executive Function: Low average level, SS 84. Language: Average range, SS 98. TOMM administered, patient successfully passed both trials, suggesting valid effort during assessment. MMPI-2-RF profile showed elevated scores on scales related to somatic complaints and diminished positive emotions, but no indication of symptom over-reporting or exaggerated distress.
* **Diagnoses:** Mild neurocognitive disorder, directly attributable to traumatic brain injury; Post-concussion syndrome.
* **Plan/Assessment:** Test results consistent with mild neurocognitive disorder resulting from traumatic brain injury. Referral for cognitive rehabilitation therapy, two sessions per week, recommended. Vocational rehabilitation assessment should be pursued to explore return-to-work options and strategies. For potential return-to-work, accommodations should include reduced screen exposure, provision of written task lists, and quiet work environment. Re-evaluation of cognitive functioning suggested in approximately six months.
* **Source References:** (DOC ID: Clearwater-Neuro-20250422-001 | PAGE 3 of 42)

## Date of Medical Visit: 06/05/2025
### 06/05/2025
* **Type of Visit:** Neurology Follow-up
* **Facility Name:** Summit Neurology Associates
* **Provider Name:** Dr. Wendy Nakamura, MD
* **Subjective/HPI/CC/Hospital Course:** Patient returns for follow-up after completing neuropsychological testing. Reports improvement in frequency of headaches, decreased from daily occurrence to about three to four times per week since starting topiramate. Cognitive symptoms persist, though slight improvement noted since engaging in cognitive rehabilitation. Describes experiencing tingling sensations in fingers on both sides, recognized as potential side effect of topiramate medication.
* **Objective/PE:** Physical exam revealed intact cranial nerves (II through XII). Motor strength 5/5 in all extremities. Sensory examination showed reduced perception of pinprick stimuli at distal fingertips bilaterally. Mini-Mental Status Examination score 29 out of 30 points.
* **Diagnoses:** Post-traumatic headache, showing signs of improvement; Post-concussion cognitive impairment, ongoing; Paresthesias induced by topiramate.
* **Medication(s):** Topiramate: Dosage adjusted. Previously 50 mg twice daily, now reduced to 25 milligrams twice daily due to reported paresthesias; Sumatriptan: Continues to be prescribed for acute migraine relief as needed; Magnesium Glycinate: Added to regimen at dose of 400 milligrams once daily for migraine prevention.
* **Plan/Assessment:** Patient instructed to continue with cognitive rehabilitation sessions. Monitor resolution of paresthesias following reduction in topiramate dosage. Should headaches worsen despite current regimen, consideration will be given to switching to propranolol as alternative prophylactic agent. Return to clinic for follow-up in eight weeks.
* **Source References:** (DOC ID: SUMMIT-NEURO-20250605-001 | PAGE 5 of 42)

## Date of Medical Visit: 07/28/2025
### 07/28/2025
* **Type of Visit:** Physical Therapy Initial Evaluation
* **Facility Name:** Pinecrest Physical Therapy & Rehabilitation
* **Provider Name:** Sarah Mitchell, DPT
* **Subjective/HPI/CC/Hospital Course:** Initial physical therapy assessment conducted for complaints of neck pain and dizziness experienced after motor vehicle accident. Patient reports stiffness in neck and episodes of dizziness, particularly when performing quick movements of head. Notes she is separately participating in cognitive rehabilitation therapy.
* **Objective/PE:** Cervical ROM: Flexion 35 degrees (norm 50), Extension 40 degrees (norm 60), Rotation Right 55 degrees (norm 80), Rotation Left 60 degrees (norm 80), Lateral Flexion Right 30 degrees (norm 45), Lateral Flexion Left 35 degrees (norm 45). Palpation: Tenderness elicited bilaterally in upper trapezius muscles and suboccipital region. Vestibular Assessment: Dix-Hallpike Maneuver negative both sides; BPPV screen negative; Reported mild dizziness upon rapid horizontal head turns. Balance Assessment: Single Leg Stance 15 seconds right, 12 seconds left (norm >30 seconds); Dynamic Gait Index score 20 out of 24, indicating mild impairment.
* **Social:** Patient not employed at time of evaluation.
* **Diagnoses:** Cervicalgia (neck pain); Cervicogenic dizziness; Vestibular dysfunction, post-concussion type.
* **Plan/Assessment:** Frequency: Two times per week. Duration: Eight weeks. Interventions to include: Vestibular rehabilitation exercises, stretching and strengthening for cervical spine, gaze stabilization techniques, and balance training. Goals: Improve cervical ROM, decrease dizziness, enhance balance, and facilitate return to prior activity level.
* **Source References:** (DOC ID: PINEPT-20250728-001 | PAGE 7 of 42)

## Date of Medical Visit: 09/15/2025
### 09/15/2025
* **Type of Visit:** Neurology Follow-up
* **Facility Name:** Summit Neurology Associates
* **Provider Name:** Dr. Wendy Nakamura, MD
* **Subjective/HPI/CC/Hospital Course:** Patient reports further reduction in headache frequency, now occurring approximately one to two times per week. Tingling sensations in fingers, previously attributed to topiramate, have completely resolved since dosage reduction. Notes significant improvement in dizziness, attributed to vestibular physical therapy. Subjectively, cognitive function feels better overall. Indicates plans to attempt returning to part-time work within next month.
* **Objective/PE:** Cranial nerve examination (II-XII) normal. Motor strength full (5/5) in all extremities. Sensory examination within normal limits. Cervical range of motion showed improvement compared to previous assessments. No nystagmus observed during oculomotor examination.
* **Diagnoses:** Post-traumatic headache, significantly improved; Post-concussion syndrome, showing ongoing improvement; Cervicogenic dizziness, now resolved.
* **Medication(s):** Topiramate 25 mg twice daily; Sumatriptan as needed; Magnesium Glycinate 400 mg daily.
* **Plan/Assessment:** Continue with current medication regimen. Consider gradual tapering of topiramate if headaches remain well-controlled. Support patient's planned return to part-time employment, emphasizing need for appropriate accommodations. Follow-up appointment scheduled in three months.
* **Source References:** (DOC ID: SUMMIT-NEURO-20250915-001 | PAGE 10 of 42)

## Date of Medical Visit: 10/20/2025
### 10/20/2025
* **Type of Visit:** Return-to-Work Evaluation
* **Facility Name:** Ridgeview Occupational Medicine
* **Provider Name:** Dr. Frank Delgado, MD, MPH
* **Subjective/HPI/CC/Hospital Course:** Patient, previously employed as data analyst before motor vehicle accident, undergoing evaluation to determine readiness to return to work on part-time basis. States headaches and cognitive abilities have shown improvement. Primary concerns revolve around tolerance for screen time and capacity for multitasking in work environment.
* **Objective/PE:** Physical exam unremarkable. Neurological examination normal. Functional Capacity Assessment: Sitting Tolerance - ability to sit continuously for two hours before requiring 10-minute break; Sustained Attention - adequate for simple, routine tasks, but showed decrease when faced with complex, multi-step assignments; Screen Tolerance - reported onset of headache after approximately 90 minutes of continuous screen exposure.
* **Diagnoses:** Post-concussion syndrome, in recovery phase; Fitness for modified duty.
* **Plan/Assessment:** Cleared for part-time work, defined as four hours per day, with following necessary restrictions: Frequent breaks from screen use, recommended every 60 to 90 minutes; Provision of written instructions for all tasks to aid memory and organization; Requirement for quiet work environment to minimize distractions; No driving for work-related purposes. Re-evaluation advised in eight weeks to assess progress and potential for progression to full-time duty.
* **Source References:** (DOC ID: RIDGEVIEW-OM-20251020-001 | PAGE 11 of 42)

## Date of Medical Visit: 12/10/2025
### 12/10/2025
* **Type of Visit:** Neurology Follow-up
* **Facility Name:** Summit Neurology Associates
* **Provider Name:** Dr. Wendy Nakamura, MD
* **Subjective/HPI/CC/Hospital Course:** Patient reports having been employed part-time for past six weeks. Headaches now infrequent, occurring approximately once per week, described as mild in intensity. Experiences no dizziness. Cognitive function generally adequate for current workload, though notes some difficulty with longer meetings. Tolerates topiramate 25 mg twice daily well.
* **Objective/PE:** Physical and neurological examination findings normal. Mini-Mental Status Examination score 30 out of 30 points, indicating good cognitive function on screening.
* **Diagnoses:** Post-traumatic headache disorder, nearing resolution; Post-concussion cognitive impairment, with mild residual symptoms.
* **Medication(s):** Topiramate 25mg Tablets; Magnesium Glycinate 400mg Capsules; Sumatriptan 50mg Tablets.
* **Plan/Assessment:** Initiate gradual taper of Topiramate: 25 mg once daily for two weeks; Then, 25 mg every other day for two weeks; Following this, discontinue medication. Continue Magnesium Glycinate 400 mg daily. Recommend follow-up with occupational medicine for assessment of full duty work. Consider repeating neuropsychological testing in approximately six months to formally document extent of recovery.
* **Source References:** (DOC ID: SUMMIT-NEURO-20251210-001 | PAGE 13 of 42)

## Date of Medical Visit: 02/18/2026
### 02/18/2026
* **Type of Visit:** Final Work Capacity Evaluation
* **Facility Name:** Ridgeview Occupational Medicine
* **Provider Name:** Dr. Frank Delgado, MD, MPH
* **Subjective/HPI/CC/Hospital Course:** Patient presents for re-evaluation regarding ability to transition to full-time employment. Reports having worked part-time (four hours per day) for past four months without experiencing any significant issues. Headaches now rare, occurring only two to three times per month. Has been off topiramate medication for four weeks. Patient denies any current dizziness or cognitive complaints at present workload.
* **Objective/PE:** Physical exam entirely normal. Functional Capacity Assessment: Sitting Tolerance - capable of sitting for four or more hours with standard breaks; Screen Tolerance - reported tolerance for screen exposure exceeding three hours; Attention - screening assessments for sustained and divided attention within normal limits.
* **Diagnoses:** Post-concussion syndrome, nearly resolved; Cleared for full-time duty with minimal restrictions.
* **Plan/Assessment:** Cleared for full-time work, defined as eight hours per day. Following minimal restrictions and recommendations advised: Recommendation for ergonomic workstation setup; Advise screen breaks every two hours; No restriction on driving for work purposes. Final follow-up with neurologist recommended to officially close the case.
* **Source References:** (DOC ID: RIDGEVIEW-OM-20260218-001 | PAGE 15 of 42)